Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

OncoCyte Corporation (OCX)

2.08   -0.11 (-5.02%) 07-16 16:00
Open: 2.19 Pre. Close: 2.19
High: 2.19 Low: 2.05
Volume: 157,314 Market Cap: 108M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.243 - 2.252 2.252 - 2.261
Low: 2.029 - 2.038 2.038 - 2.047
Close: 2.174 - 2.19 2.19 - 2.204

Technical analysis

as of: 2019-07-16 3:22:57 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.96     One year: 5.06
Support: Support1: 1.88    Support2: 1.56
Resistance: Resistance1: 3.39    Resistance2: 4.33
Pivot: 2.33
Moving Average: MA(5): 2.11     MA(20): 2.71
MA(100): 3.78     MA(250): 2.90
MACD: MACD(12,26): -0.49     Signal(9): -0.49
Stochastic oscillator: %K(14,3): 9.87     %D(3): 9.09
RSI: RSI(14): 35.95
52-week: High: 6.92  Low: 1.16  Change(%): -26.7
Average Vol(K): 3-Month: 36189  10-Days: 54706

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OCX has closed above bottom band by 37.4%. Bollinger Bands are 53.9% wider than normal. The large width of the bands suggest high volatility as compared to OCX's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Wed, 26 Jun 2019 21:16:58 Z
Mid-Afternoon Market Update: Micron Technology Jumps On Upbeat Q3 Results; OncoCyte Shares Slide

Wed, 26 Jun 2019 19:08:37 Z
Wednesday Sector Laggards: Cigarettes & Tobacco, Diagnostics

Wed, 26 Jun 2019 18:37:15 Z
Mid-Day Market Update: Crude Oil Up 2.9%; Gemphire Therapeutics Shares Plummet

Wed, 26 Jun 2019 16:07:07 Z
Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Strong Q1 Results

Mon, 20 May 2019 16:14:15 Z
OncoCyte (OCX) Catches Eye: Stock Jumps 7.3%

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 20.27
% Held by Insiders 47.30
% Held by Institutions 21.97
Shares Short (K) 583
Shares Short P. Month (K)

Stock Financials

EPS -0.381
EPS Est. Current Year -0.540
EPS Est. Next Year -0.540
EPS Est. Next Quarter -0.130
Forward EPS -0.470
Book Value (p.s.) 0.740
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -32.0
Return on Equity (ttm) -67.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.272
Qtrly Earnings Growth
Operating Cash Flow (M) -15.61
Levered Free Cash Flow (M) -9.76

Stock Valuations

P/E -5.49
P/E Growth Ratio -0.05
P/BV 2.82
P/S
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.